2-[4-[1-[4-(2-PYRIDYL)-PIPERAZINYL]]-BUTYL]-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE
Compound with spectra: 1 NMR
![2-[4-[1-[4-(2-PYRIDYL)-PIPERAZINYL]]-BUTYL]-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE](/api/compound/4st9gry4glF.png?ph=true&h=300&w=458 "2-[4-[1-[4-(2-PYRIDYL)-PIPERAZINYL]]-BUTYL]-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE")
| SpectraBase Compound ID | 4st9gry4glF |
|---|---|
| InChI | InChI=1S/C18H23N5O3S2/c24-18-20-17-15(6-14-27-17)28(25,26)23(18)9-4-3-8-21-10-12-22(13-11-21)16-5-1-2-7-19-16/h1-2,5-7,14H,3-4,8-13H2,(H,20,24) |
| InChIKey | VQVPRPXZMLOCAU-UHFFFAOYSA-N |
| Mol Weight | 421.53 g/mol |
| Molecular Formula | C18H23N5O3S2 |
| Exact Mass | 421.124232 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-[4-[1-[4-(4-FLUOROPHENYL)-PIPERAZINYL]]-BUTYL]-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE
2-[3-[1-[4-(4-FLUOROPHENYL)-PIPERAZINYL]]-PROPYL]-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE-MONO-HYDROBROMIDE
2-ALLYL-6-BROMO-2H-THIENO-[2,3-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE
2-ALLYL-5-BROMO-2H-THIENO-[3,4-E]-[1,2,4]-THIADIAZIN-3(4H)-ONE-1,1-DIOXIDE
3,4-DIHYDRO-2H-[1,3]-OXAZINO-[3,2-B]-THIENO-[3,4-E]-[1,2,4]-THIADIAZINE-6,6-DIOXIDE
4(1H)-quinazolinone, 2,3-dihydro-3-[2-oxo-2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]-2-thioxo-
Pyrido[1,2-b][1,2,4]benzothiadiazine, 7,8,9,10,10a,11-hexahydro-, 5,5-dioxide
1,3-benzodioxole-5-carbaldehyde [2-(hexahydro-1H-azepin-1-ylsulfonyl)-4-nitrophenyl]hydrazone
1-(3-chloro-4-methylphenyl)-3-[4-(2-pyridinyl)-1-piperazinyl]-2,5-pyrrolidinedione
1-(3,4-dichlorophenyl)-3-[4-(2-pyridinyl)-1-piperazinyl]-2,5-pyrrolidinedione
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of new hetero[1,2,4]thiadiazin-3-one S,S-dioxides and oxazolo[3,2-b]hetero[1,2,4]thiadiazine S,S-dioxides as potential psychotropic drugs | Journal of Heterocyclic Chemistry | 2005 |